Table of Contents
ISRN Chromatography
Volume 2013 (2013), Article ID 329072, 6 pages
http://dx.doi.org/10.1155/2013/329072
Research Article

High-Performance Liquid Chromatographic Method for Analysis of Emtricitabine in Rat Plasma: Method Development, Validation and Application to a Pharmacokinetic Study

Department of Pharmaceutics, Faculty of Pharmacy, Al-Ameen College of Pharmacy, Near Lal Bagh Main gate, Hosur Road, Bangalore, Karnataka 560027, India

Received 16 August 2013; Accepted 8 October 2013

Academic Editors: F. Couderc, C. Fanali, J. Millership, and F. J. Señoráns

Copyright © 2013 Gurinder Singh and Roopa S. Pai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. H. Wang, A. A. Wiznia, M. H. Rathore et al., “Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 183–191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. D. Hamarapurkar and A. N. Parate, “HPLC method for the determination of emtricitabine and related degradation substances,” The Journal of Chromatographic Science, vol. 51, no. 5, pp. 419–424, 2013. View at Publisher · View at Google Scholar
  3. Y. van Herrewege, J. Michiels, J. van Roey et al., “In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 337–339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Terrazas-Aranda, Y. van Herrewege, P. J. Lewi, J. van Roey, and G. Vanham, “In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection,” Antiviral Chemistry and Chemotherapy, vol. 18, no. 3, pp. 141–151, 2007. View at Google Scholar · View at Scopus
  5. S. di Fabio, J. van Roey, G. Giannini et al., “Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation,” AIDS, vol. 17, no. 11, pp. 1597–1604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Darque, G. Valette, F. Rousseau, L. H. Wang, J.-P. Sommadossi, and X.-J. Zhou, “Quantitation of intracellular triphosphate of emtricitabine in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 9, pp. 2245–2250, 1999. View at Google Scholar · View at Scopus
  7. N. L. Rezk, R. D. Crutchley, and A. D. M. Kashuba, “Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction,” Journal of Chromatography B, vol. 822, no. 1-2, pp. 201–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Peepliwal and C. G. Bonde, “Determination of emtricitabine in human plasma by RP-HPLC with UV-detection,” Journal of Pharmacy Research, vol. 3, no. 8, pp. 1712–1715, 2010. View at Google Scholar
  9. N. A. Gomes, V. V. Vaidya, A. Pudage, S. S. Joshi, and S. A. Parekh, “Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 918–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Karunakaran, K. Kamarajan, and V. Thangarasu, “A validated RP-HPLC method for simulataneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and in tablet dosage form,” Der Pharmacia Sinica, vol. 1, no. 2, pp. 52–56, 2010. View at Google Scholar
  11. P. S. Devrukhakar, R. Borkar, N. Shastri, and K. V. H. Surendranat, “A validated stability-indicating rp-hplc method for the simultaneous determination of tenofovir, emtricitabine, and an efavirenz and statistical approach to determine the effect of variables,” ISRN Chromatography, vol. 2013, Article ID 878295, 8 pages, 2013. View at Publisher · View at Google Scholar
  12. P. Kumar, S. C. Dwivedi, and A. kushnoor, “A validated stability indicating RP-HPLC method for the determination of emtricitabine in bulk and capsules,” Farmacia, vol. 60, no. 3, pp. 402–410, 2012. View at Google Scholar
  13. C. Mathew, M. Ajitha, and P. R. S. Babu, “Cefpodoxime proxetil: a new stability indicating RP-HPLC method,” ISRN Chromatography, vol. 2013, Article ID 328157, 8 pages, 2013. View at Publisher · View at Google Scholar
  14. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, Md, USA, 2001.
  15. ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Methodology, Q2 (R1), International Conference on Harmonisation of Technical Requirements for Registrations of Pharmaceuticals for Human Use, ICH, Geneva, Switzerland, 2005.
  16. R. Nirogi, G. Bhyrapuneni, V. Kandikere et al., “Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats,” Biopharmaceutics & Drug Disposition, vol. 33, no. 5, pp. 265–277, 2012. View at Publisher · View at Google Scholar